{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T18:15:39Z","timestamp":1791569739275,"version":"4.3.4"},"reference-count":44,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.ejso.2025.110537","type":"journal-article","created":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T07:00:39Z","timestamp":1761116439000},"page":"110537","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Pre-operative predictors of completeness of cytoreduction for colorectal peritoneal metastases: a systematic review of radiological, clinicopathological and biomarker-based predictors"],"prefix":"10.1016","volume":"51","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3219-3938","authenticated-orcid":false,"given":"Samuel","family":"Pau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"Eglinton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesse","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejso.2025.110537_bib1","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/5180895","article-title":"Colorectal peritoneal metastases: a systematic review of current and emerging trends in clinical and translational research","volume":"2019","author":"Koumpa","year":"2019","journal-title":"Gastroenterol Res Pract"},{"issue":"12","key":"10.1016\/j.ejso.2025.110537_bib2","doi-asserted-by":"crossref","first-page":"2622","DOI":"10.1002\/(SICI)1097-0142(19960615)77:12<2622::AID-CNCR28>3.0.CO;2-T","article-title":"Analysis of morbidity and mortality in 60 patients with peritoneal carcinomatosis treated by cytoreductive surgery and heated intraoperative intraperitoneal chemotherapy","volume":"77","author":"Jacquet","year":"1996","journal-title":"Cancer"},{"issue":"5","key":"10.1016\/j.ejso.2025.110537_bib3","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.surge.2020.08.016","article-title":"Survival after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastases: a systematic review and discussion of latest controversies","volume":"19","author":"Flood","year":"2021","journal-title":"Surgeon"},{"key":"10.1016\/j.ejso.2025.110537_bib4","article-title":"Long-term survival following cytoreductive surgery and HIPEC in Waikato, Aotearoa New Zealand: a 12-year experience","author":"Qin","year":"2023","journal-title":"ANZ J Surg"},{"issue":"3","key":"10.1016\/j.ejso.2025.110537_bib5","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/DCR.0b013e318202f026","article-title":"Operative findings and survival in pseudomyxoma peritonei syndrome","volume":"54","author":"Youssef","year":"2011","journal-title":"Dis Colon Rectum"},{"issue":"5","key":"10.1016\/j.ejso.2025.110537_bib6","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.ejso.2010.01.006","article-title":"Pseudomyxoma peritonei: a French multicentric study","volume":"36","author":"Elias","year":"2010","journal-title":"Eur J Surg Oncol"},{"issue":"21","key":"10.1016\/j.ejso.2025.110537_bib7","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1200\/JCO.2011.39.7166","article-title":"Outcomes of pseudomyxoma peritonei from appendiceal origin treated by CRS-HIPEC","volume":"30","author":"Chua","year":"2012","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.ejso.2025.110537_bib8","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1002\/bjs5.50134","article-title":"Factors influencing long-term survival after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei originating from appendiceal neoplasms","volume":"3","author":"van Eden","year":"2019","journal-title":"BJS Open"},{"issue":"5","key":"10.1016\/j.ejso.2025.110537_bib9","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1002\/bjs5.50179","article-title":"Meta-analysis of prognostic factors for patients with colorectal peritoneal metastasis undergoing cytoreductive surgery and heated intraperitoneal chemotherapy","volume":"3","author":"Hallam","year":"2019","journal-title":"BJS Open"},{"issue":"2","key":"10.1016\/j.ejso.2025.110537_bib10","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1159\/000522310","article-title":"Incomplete cytoreduction of colorectal cancer peritoneal metastases: survival outcomes by a cytoreduction score","volume":"38","author":"Sugarbaker","year":"2022","journal-title":"Visc Med"},{"issue":"6","key":"10.1016\/j.ejso.2025.110537_bib11","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.jamcollsurg.2006.08.024","article-title":"Analysis of 10 prognostic factors in 70 patients having complete cytoreduction plus perioperative intraperitoneal chemotherapy for carcinomatosis from colorectal cancer","volume":"203","author":"Gomes da Silva","year":"2006","journal-title":"J Am Coll Surg"},{"issue":"1","key":"10.1016\/j.ejso.2025.110537_bib12","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1245\/s10434-015-4627-8","article-title":"Linear relationship of peritoneal cancer index and survival in patients with peritoneal metastases from colorectal cancer","volume":"23","author":"Faron","year":"2016","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"10.1016\/j.ejso.2025.110537_bib13","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1245\/s10434-014-4148-x","article-title":"Peritoneal cancer patients not suitable for cytoreductive surgery and HIPEC during explorative surgery: risk factors, treatment options, and prognosis","volume":"22","author":"van Oudheusden","year":"2015","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"10.1016\/j.ejso.2025.110537_bib14","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.ejso.2020.09.010","article-title":"Cost-analysis of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with peritoneal malignancy: an Australian perspective with global application","volume":"47","author":"McBride","year":"2021","journal-title":"Eur J Surg Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2025.110537_bib15","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s13643-016-0384-4","article-title":"Rayyan\u2014A web and mobile app for systematic reviews","volume":"5","author":"Ouzzani","year":"2016","journal-title":"Syst Rev"},{"issue":"8","key":"10.1016\/j.ejso.2025.110537_bib16","doi-asserted-by":"crossref","first-page":"756.e11","DOI":"10.1016\/j.crad.2018.03.011","article-title":"Preoperative CT-based predictive factors for resectability and medium-term overall survival in patients with peritoneal carcinomatosis from colorectal cancer","volume":"73","author":"Suzuki","year":"2018","journal-title":"Clin Radiol"},{"issue":"4","key":"10.1016\/j.ejso.2025.110537_bib17","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1002\/bjs.10989","article-title":"Diffusion-weighted MRI assessment of the peritoneal cancer index before cytoreductive surgery","volume":"106","author":"van 't Sant","year":"2019","journal-title":"Br J Surg"},{"issue":"6","key":"10.1016\/j.ejso.2025.110537_bib18","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1177\/02841851241229154","article-title":"The importance of integrating diagnostic modalities in patient selection for CRS-HIPEC in colorectal peritoneal metastases","volume":"65","author":"de Boer","year":"2024","journal-title":"Acta Radiol"},{"key":"10.1016\/j.ejso.2025.110537_bib19","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s12957-019-1673-x","article-title":"A novel pre-operative predictive score for unresectability in colorectal peritoneal metastases","volume":"17","author":"Yong","year":"2019","journal-title":"World J Surg Oncol"},{"issue":"6","key":"10.1016\/j.ejso.2025.110537_bib20","first-page":"647","article-title":"Preoperative criteria of incomplete resectability of peritoneal carcinomatosis from non-appendiceal colorectal carcinoma","volume":"31","author":"Elias","year":"2005","journal-title":"Eur J Surg Oncol"},{"issue":"4","key":"10.1016\/j.ejso.2025.110537_bib21","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jnci.2018.10.004","article-title":"Peritoneal carcinomatosis in colorectal cancer: defining predictive factors for successful cytoreductive surgery and hyperthermic intraperitoneal chemotherapy \u2013 a pilot study","volume":"30","author":"Mahmoud","year":"2018","journal-title":"J Egypt Natl Cancer Inst"},{"issue":"2","key":"10.1016\/j.ejso.2025.110537_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejso.2023.107251","article-title":"Predictive factors of non-completion of cytoreductive surgery in colorectal peritoneal metastasis","volume":"50","author":"Boldrin","year":"2024","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ejso.2025.110537_bib23","article-title":"18F-FAPI-42 PET\/CT enhances the diagnostic efficacy for peritoneal metastasis of colorectal cancer and guides treatment decisions: an original retrospective study","volume":"12","author":"Zhang","year":"2024","journal-title":"Gastroenterol Rep (Oxf)"},{"issue":"4","key":"10.1016\/j.ejso.2025.110537_bib24","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1245\/s10434-016-5698-x","article-title":"Management for peritoneal metastasis of colonic origin: role of cytoreductive surgery and perioperative intraperitoneal chemotherapy\u2014a single institution's experience during two decades","volume":"24","author":"Ihemelandu","year":"2017","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"10.1016\/j.ejso.2025.110537_bib25","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1245\/s10434-014-4148-x","article-title":"Peritoneal cancer patients not suitable for CRS-HIPEC during explorative surgery: risk factors and prognosis","volume":"22","author":"van Oudheusden","year":"2015","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2025.110537_bib26","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1007\/s10147-012-0505-6","article-title":"Outcomes of surgery without HIPEC for synchronous peritoneal metastasis from colorectal cancer: data from a multi-center registry","volume":"19","author":"Kobayashi","year":"2014","journal-title":"Int J Clin Oncol"},{"issue":"7","key":"10.1016\/j.ejso.2025.110537_bib27","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1245\/s10434-019-07373-0","article-title":"Primary tumor sidedness is predictive of survival in colon cancer patients treated with cytoreductive surgery with or without HIPEC: a US HIPEC Collaborative Study","volume":"26","author":"Kotha","year":"2019","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"10.1016\/j.ejso.2025.110537_bib28","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1097\/XCS.0000000000000091","article-title":"Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for management of colorectal cancer with peritoneal dissemination: 30 years of experience at a single institution","volume":"234","author":"Lundy","year":"2022","journal-title":"J Am Coll Surg"},{"issue":"1","key":"10.1016\/j.ejso.2025.110537_bib29","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s13193-019-00879-9","article-title":"Chasing rainbows? The possibility of \u201ccure\u201d in patients with colorectal peritoneal metastases undergoing cytoreductive surgery and HIPEC\u2014A retrospective study by INDEPSO","volume":"10","author":"Bhatt","year":"2019","journal-title":"Indian J Surg Oncol"},{"key":"10.1016\/j.ejso.2025.110537_bib30","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1186\/s12957-021-02374-4","article-title":"Does the primary tumour location affect the prognosis of patients with colorectal cancer peritoneal metastases treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy?","volume":"19","author":"Chen","year":"2021","journal-title":"World J Surg Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2025.110537_bib31","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.ejso.2016.09.010","article-title":"Curative cytoreductive surgery followed by hyperthermic intraperitoneal chemotherapy in patients with peritoneal carcinomatosis and synchronous resectable liver metastases arising from colorectal cancer","volume":"43","author":"Lorimier","year":"2017","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ejso.2025.110537_bib32","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1186\/s12957-022-02765-1","article-title":"The prognostic impact of lead times in colorectal cancer patients undergoing cytoreductive surgery and HIPEC","volume":"20","author":"Jansson","year":"2022","journal-title":"World J Surg Oncol"},{"issue":"13","key":"10.1016\/j.ejso.2025.110537_bib33","doi-asserted-by":"crossref","first-page":"4183","DOI":"10.1245\/s10434-013-3204-2","article-title":"Comparison of prognostic scores for patients with colorectal cancer peritoneal metastases treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy","volume":"20","author":"Cashin","year":"2013","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"10.1016\/j.ejso.2025.110537_bib34","doi-asserted-by":"crossref","first-page":"3638","DOI":"10.1245\/s10434-024-16860-y","article-title":"Patterns of preoperative tumor markers can predict resectability and prognosis of peritoneal metastases: a clustering analysis","volume":"32","author":"Enblad","year":"2025","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2025.110537_bib35","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.suronc.2020.09.002","article-title":"Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy in patients with peritoneal carcinomatosis from colorectal cancer: the prognostic impact of baseline neutrophil-lymphocyte, platelet-lymphocyte and lymphocyte-monocyte ratios","volume":"35","author":"Zager","year":"2020","journal-title":"Surg Oncol"},{"issue":"4","key":"10.1016\/j.ejso.2025.110537_bib36","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1002\/ags3.12918","article-title":"Clinical significance of preoperative Glasgow prognostic score in patients with colorectal cancer and synchronous peritoneal metastases","volume":"9","author":"Fujimoto","year":"2025","journal-title":"Ann Gastroenterol Surg"},{"issue":"4","key":"10.1016\/j.ejso.2025.110537_bib37","doi-asserted-by":"crossref","first-page":"87","DOI":"10.4240\/wjgs.v4.i4.87","article-title":"Malignant ascites: a review of prognostic factors, pathophysiology, and therapeutic measures","volume":"4","author":"Sangisetty","year":"2012","journal-title":"World J Gastrointest Surg"},{"issue":"4","key":"10.1016\/j.ejso.2025.110537_bib38","first-page":"947","article-title":"A deep-learning model to predict the completeness of cytoreductive surgery in colorectal cancer with peritoneal metastasis","volume":"49","author":"Lin","year":"2023","journal-title":"Eur J Surg Oncol"},{"issue":"12","key":"10.1016\/j.ejso.2025.110537_bib39","doi-asserted-by":"crossref","first-page":"370","DOI":"10.4240\/wjgs.v7.i12.370","article-title":"Hypoalbuminemia in colorectal cancer prognosis: nutritional marker or inflammatory surrogate?","volume":"7","author":"Nazha","year":"2015","journal-title":"World J Gastrointest Surg"},{"issue":"1","key":"10.1016\/j.ejso.2025.110537_bib40","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-80803-6","article-title":"Systemic inflammatory response in colorectal cancer is associated with tumour mismatch repair and impaired survival","volume":"14","author":"Hjortborg","year":"2024","journal-title":"Sci Rep"},{"issue":"9","key":"10.1016\/j.ejso.2025.110537_bib41","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.3390\/cancers12092536","article-title":"Retrospective analysis of patients with signet ring subtype of colorectal cancer with peritoneal metastasis treated with CRS & HIPEC","volume":"12","author":"Prabhu","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.ejso.2025.110537_bib42","first-page":"1","article-title":"An insight into the peculiarities of signet-ring cell carcinoma of the colon \u2013 a narrative review","volume":"4","author":"Farca\u015f","year":"2024","journal-title":"Med Oncol"},{"issue":"24","key":"10.1016\/j.ejso.2025.110537_bib43","first-page":"4539","article-title":"The peritoneal \u201csoil\u201d for a cancerous \u201cseed\u201d: a comprehensive review of the pathogenesis of intraperitoneal cancer metastases","volume":"75","author":"Mikula-Pietrasik","year":"2018","journal-title":"Cell Mol Life Sci"},{"issue":"1","key":"10.1016\/j.ejso.2025.110537_bib44","doi-asserted-by":"crossref","first-page":"143","DOI":"10.3390\/gidisord6010010","article-title":"Developing a core outcome set for cytoreductive surgery for colorectal cancer with peritoneal metastases: a mixed-method study protocol","volume":"6","author":"Raichurkar","year":"2024","journal-title":"Gastrointest Disord"}],"container-title":["European Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798325009655?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798325009655?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T23:53:47Z","timestamp":1764028427000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798325009655"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":44,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S0748798325009655"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2025.110537","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pre-operative predictors of completeness of cytoreduction for colorectal peritoneal metastases: a systematic review of radiological, clinicopathological and biomarker-based predictors","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2025.110537","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110537"}}